Additive effect of the metabolic syndrome score to the conventional CHADS2 score for the thromboembolic risk stratification of patients with atrial fibrillation

Heart Rhythm

Volumn 11, Issue 3, 2014, Pages 352-357

  Tsai, Chia Ti ^a   Chang, Shu Hsuan ^b   Chang, Sheng Nan ^a   Hwang, Juey Jen ^a   Wu, Cho Kai ^a   Wang, Yi Chih ^a   Tseng, Chuen Den ^a   Yeh, Huei Ming ^a   Lai, Ling Ping ^a   Chiang, Fu Tien ^a   Lin, Jiunn Lee ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b LOTUNG POH AI HOSPITAL   (Taiwan)

Author keywords

Atrial fibrillation; Metabolic syndrome; Stroke; Thromboembolism

Indexed keywords

ATRIAL FIBRILLATION; METABOLIC SYNDROME; STROKE; THROMBOEMBOLISM;

AGED; ATRIAL FIBRILLATION; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; TAIWAN; THROMBOEMBOLISM;

EID: 84894517202     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2013.11.014     Document Type: Article

References (27)

1. Stroke Risk in Atrial Fibrillation Working Group Independent predictors of stroke in patients with atrial fibrillation: a systematic review Neurology 69 2007 546 554
2. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation J Am Med Assoc 285 2001 2864 2870
3. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation Chest 137 2010 263 272
4. L.Y. Lin, C.H. Lee, and C.C. Yu et al. Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation - a nationwide database analysis Atherosclerosis 217 2011 292 295
5. M.L. Zuo, S. Liu, and K.H. Chan et al. The CHADS(2) and CHA(2)DS(2)-VASc scores predict new occurrence of atrial fibrillation and ischemic stroke J Interv Card Electrophysiol 37 2013 47 54
6. B. Boden-Albala, R.L. Sacco, and H.S. Lee et al. Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study Stroke 39 2008 30 35
7. S.M. Rodriguez-Colon, J. Mo, and Y. Duan et al. Metabolic syndrome clusters and the risk of incident stroke: the Atherosclerosis Risk in Communities (ARIC) Study Stroke 40 2009 200 205
8. C.T. Tsai, L.P. Lai, and J.L. Lin et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation Circulation 109 2004 1640 1646
9. C.T. Tsai, J.J. Hwang, and F.T. Chiang et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation: a regression approach for the detection of gene-gene interactions in a large hospitalized population Cardiology 111 2008 1 7
10. K.G. Alberti, P. Zimmet, and J. Shaw Metabolic syndrome - a new world-wide definition. A Consensus Statement from the International Diabetes Federation Diabet Med 23 2006 469 480
11. M.C. Alessi, and I. Juhan-Vague Metabolic syndrome, haemostasis and thrombosis Thromb Haemost 99 2008 995 1000
12. S.S. Anand, Q. Yi, and H. Gerstein et al. Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease Circulation 108 2003 420 425
13. M. Nieuwdorp, E.S. Stroes, J.C. Meijers, and H. Büller Hypercoagulability in the metabolic syndrome Curr Opin Pharmacol 5 2005 155 159
14. M.R. Di Tullio, R.L. Sacco, R.R. Sciacca, and S. Homma Left atrial size and the risk of ischemic stroke in an ethnically mixed population Stroke 30 1999 2019 2024
15. A. Bouzas-Mosquera, F.J. Broullón, and N. Álvarez- García et al. Left atrial size and risk for all-cause mortality and ischemic stroke CMAJ 12 2011 E657 E664
16. A. Azevedo, P. Bettencourt, and P.B. Almeida et al. Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities - cross-sectional study of the general population BMC Cardiovasc Disord 7 2007 17
17. V.N. Nicolaou, J.E. Papadakis, E.N. Karatzis, S.I. Dermitzaki, A.K. Tsakiris, and P.D. Skoufas Impact of the metabolic syndrome on atrial size in patients with new-onset atrial fibrillation Angiology 8 2007 21 25
18. T.J. Wang, H. Parise, and D. Levy et al. Obesity and the risk of new-onset atrial fibrillation J Am Med Assoc 292 2004 2471 2477
19. D. Penjasković, D. Sakac, J. Dejanović, R. Zec, N. Zec Petković, and A. Stojsić Milosavljević Left ventricular dysfunction in patients with metabolic syndrome Med Pregl 65 2012 18 22
20. G.G. Blume, C.J. Mcleod, and M.E. Barnes et al. Left atrial function: physiology, assessment, and clinical implications Eur J Echocardiogr 12 2011 421 430
21. M.A. Rosenberg, and W.J. Manning Diastolic dysfunction and risk of atrial fibrillation: a mechanistic appraisal Circulation 126 2012 2353 2362
22. T. Watson, E. Shantsila, and G.Y. Lip Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited Lancet 373 2009 155 166
23. T. Yamashita Molecular basis of thromboembolism in association with atrial fibrillation Circ J 71 2007 A40 A44
24. A.A. Lteif, K. Han, and K.J. Mather Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks Circulation 112 2005 32 38
25. S. Czernichow, J.R. Greenfield, and P. Galan Macrovascular and microvascular dysfunction in the metabolic syndrome Hypertens Res 33 2010 293 297
26. C. Keogh, E. Wallace, C. Dillon, B.D. Dimitrov, and T. Fahey Validation of the CHADS2 clinical prediction rule to predict ischemic stroke: a systematic review and meta-analysis Thromb Haemost 106 2011 528 538
27. J.B. Olesen, C. Torp-Pedersen, M.L. Hansen, and G.Y. Lip The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study Thromb Haemost 107 2012 1172 1179